Butchko G. Julia's most recent trade in Immunovant Inc was a trade of 2,907 Common Stock done at an average price of $31.8 . Disclosure was reported to the exchange on Aug. 21, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 21 Aug 2024 | 2,907 | 441,079 (0%) | 0% | 31.8 | 92,559 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 21 Aug 2024 | 120 | 440,959 (0%) | 0% | 32.3 | 3,878 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 17 Jul 2024 | 2,698 | 444,155 (0%) | 0% | 29.6 | 79,969 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 17 Jul 2024 | 169 | 443,986 (0%) | 0% | 30.6 | 5,163 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 09 Jul 2024 | 1,527 | 446,853 (0%) | 0% | 28.1 | 42,848 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 22 May 2024 | 3,247 | 448,380 (0%) | 0% | 29.7 | 96,274 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 17 Apr 2024 | 7,825 | 453,917 (0%) | 0% | 28.8 | 225,360 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 17 Apr 2024 | 2,290 | 451,627 (0%) | 0% | 29.9 | 68,563 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 09 Apr 2024 | 1,053 | 461,742 (0%) | 0% | 31.2 | 32,833 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 02 Apr 2024 | 68,723 | 68,723 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 02 Apr 2024 | 54,978 | 462,795 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Butchko G. Julia | Chief Development Officer | 22 Feb 2024 | 2,146 | 407,817 (0%) | 0% | 36.2 | 77,578 | Common Stock | |
| Immunovant Inc | Butchko Julia G. | Chief Development Officer | 05 Jan 2024 | 1,297 | 409,963 (0%) | 0% | 38.6 | 50,051 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 24 Aug 2023 | 12,332 | 416,261 (0%) | 0% | 20.3 | 250,340 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 24 Aug 2023 | 1 | 416,260 (0%) | 0% | 21 | 21 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 12 Jul 2023 | 1,470 | 428,593 (0%) | 0% | 19.7 | 29,003 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | 18 Apr 2023 | 1,544 | 430,063 (0%) | 0% | 15.3 | 23,577 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 12 Apr 2023 | 130,081 | 130,081 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 12 Apr 2023 | 100,188 | 431,607 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 11 Jan 2023 | 60,471 | 331,419 (0%) | 0% | 16.8 | 1,015,308 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 11 Jan 2023 | 19 | 391,890 (0%) | 0% | 15.2 | 288 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 13 Oct 2022 | 928 | 391,909 (0%) | 0% | 9.2 | 8,519 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 28 Sep 2022 | 535 | 392,837 (0%) | 0% | 4.7 | 2,498 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 30 Aug 2022 | 548 | 393,372 (0%) | 0% | 5.8 | 3,195 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 17 Aug 2022 | 169,648 | 169,648 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 17 Aug 2022 | 112,816 | 393,920 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 27 Jul 2022 | 510 | 281,104 (0%) | 0% | 4.3 | 2,178 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 29 Jun 2022 | 460 | 281,614 (0%) | 0% | 4.0 | 1,849 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 24 May 2022 | 492 | 282,074 (0%) | 0% | 3.8 | 1,865 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 27 Apr 2022 | 541 | 282,566 (0%) | 0% | 4.7 | 2,554 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 24 Mar 2022 | 6,381 | 283,107 (0%) | 0% | 5.9 | 37,648 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 07 Jan 2022 | 55,318 | 289,488 (0%) | 0% | 7.3 | 401,056 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 11 Sep 2021 | 319,700 | 319,700 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 11 Sep 2021 | 319,700 | 0 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 11 Sep 2021 | 191,100 | 0 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 11 Sep 2021 | 191,100 | 191,100 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 03 Aug 2021 | 285,306 | 344,806 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 19 Mar 2021 | 191,100 | 191,100 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 19 Mar 2021 | 54,500 | 59,500 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | 11 Sep 2020 | 5,000 | 5,000 (0%) | 0% | 38.2 | 190,850 | Common Stock |